{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T18:21:07Z","timestamp":1781288467332,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001250","name":"Morris Animal Foundation","doi-asserted-by":"publisher","award":["D15CA-052"],"award-info":[{"award-number":["D15CA-052"]}],"id":[{"id":"10.13039\/100001250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s11259-018-9737-x","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T19:12:40Z","timestamp":1536088360000},"page":"283-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-9853","authenticated-orcid":false,"given":"Karin","family":"Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans S.","family":"Kooistra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Galac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"key":"9737_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1365-2826.2008.01709.x","volume":"20","author":"AB Bicknell","year":"2008","unstructured":"Bicknell AB (2008) The tissue-specific processing of pro-opiomelanocortin. J Neuroendocrinol 20:692\u2013699. \n                    https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01709.x","journal-title":"J Neuroendocrinol"},{"key":"9737_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.mce.2014.07.003","volume":"394","author":"E Bouw","year":"2014","unstructured":"Bouw E, Huisman M, Neggers SJCMM, Themmen APN, van der Lely AJ, Delhanty PJD (2014) Development of potent selective competitive-antagonists of the melanocortin type 2 receptor. Mol Cell Endocrinol 394:99\u2013104. \n                    https:\/\/doi.org\/10.1016\/j.mce.2014.07.003","journal-title":"Mol Cell Endocrinol"},{"key":"9737_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ab.2006.06.001","volume":"356","author":"B Brinkhof","year":"2006","unstructured":"Brinkhof B, Spee B, Rothuizen J, Penning LC (2006) Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem 356:36\u201343. \n                    https:\/\/doi.org\/10.1016\/j.ab.2006.06.001","journal-title":"Anal Biochem"},{"key":"9737_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.domaniend.2010.10.002","volume":"40","author":"WA Burkhardt","year":"2011","unstructured":"Burkhardt WA, Guscetti F, Boretti FS, Todesco AI, Aldajarov N, Lutz TA, Reusch CE, Sieber-Ruckstuhl NS (2011) Adrenocorticotropic hormone, but not trilostane, causes severe adrenal hemorrhage, vacuolization, and apoptosis in rats. Domest Anim Endocrinol 40:155\u2013164. \n                    https:\/\/doi.org\/10.1016\/j.domaniend.2010.10.002","journal-title":"Domest Anim Endocrinol"},{"key":"9737_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ygcen.2013.01.017","volume":"188","author":"JM Cerd\u00e1-Reverter","year":"2012","unstructured":"Cerd\u00e1-Reverter JM, Agulleiro MJ, Cort\u00e9s R, S\u00e1nchez E, Guillot R, Leal E, Fern\u00e1ndez-Dur\u00e1n B, Puchol S, Eley M (2012) Involvement of melanocortin receptor accessory proteins (MRAPs) in the function of melanocortin receptors. Gen Comp Endocrinol 188:133\u2013136. \n                    https:\/\/doi.org\/10.1016\/j.ygcen.2013.01.017","journal-title":"Gen Comp Endocrinol"},{"key":"9737_CR6","doi-asserted-by":"publisher","unstructured":"Clark AJ, Forfar R, Hussain M, Jerman J, McIver E, Taylor D, Chan L (2016) ACTH antagonists. Front Endocrinol (Lausanne) 7. \n                    https:\/\/doi.org\/10.3389\/fendo.2016.00101","DOI":"10.3389\/fendo.2016.00101"},{"key":"9737_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1210\/en.2010-1053","volume":"152","author":"SN Cooray","year":"2011","unstructured":"Cooray SN, Chung TT, Mazhar K, Szidonya L, Clark AJL (2011) Bioluminescence resonance energy transfer reveals the adrenocorticotropin (ACTH)-induced conformational change of the activated ACTH receptor complex in living cells. Endocrinology 152:495\u2013502. \n                    https:\/\/doi.org\/10.1210\/en.2010-1053","journal-title":"Endocrinology"},{"key":"9737_CR8","unstructured":"Dores RM (2013) ACTH antagonist peptides. US Patent Application US 8,524,664 B2"},{"key":"9737_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/JME-14-0050","volume":"52","author":"RM Dores","year":"2014","unstructured":"Dores RM, Londraville RL, Prokop J, Davis P, Dewey N, Lesinski N (2014) Molecular evolution of GPCRs: Melanocortin\/melanocortin receptors. J Mol Endocrinol 52:29\u201342. \n                    https:\/\/doi.org\/10.1530\/JME-14-0050","journal-title":"J Mol Endocrinol"},{"key":"9737_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.tvjl.2008.10.007","volume":"183","author":"S Galac","year":"2010","unstructured":"Galac S, Buijtels JJCWM, Mol JA, Kooistra HS (2010a) Effects of trilostane on the pituitary-adrenocortical and renin-aldosterone axis in dogs with pituitary-dependent hypercortisolism. Vet J 183:75\u201380. \n                    https:\/\/doi.org\/10.1016\/j.tvjl.2008.10.007","journal-title":"Vet J"},{"key":"9737_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.domaniend.2010.07.001","volume":"39","author":"S Galac","year":"2010","unstructured":"Galac S, Kool MMJ, Naan EC, Daminet S, Mol JA, Kooistra HS (2010b) Expression of the ACTH receptor, steroidogenic acute regulatory protein, and steroidogenic enzymes in canine cortisol-secreting adrenocortical tumors. Domest Anim Endocrinol 39:259\u2013267. \n                    https:\/\/doi.org\/10.1016\/j.domaniend.2010.07.001","journal-title":"Domest Anim Endocrinol"},{"key":"9737_CR12","unstructured":"Galac S, Reusch CE, Kooistra HS, Rijnberk A (2010c) Adrenals. In: A. R, Kooistra HS (eds) Clinical endocrinology of dogs and cats, Second. Schl\u00fctersche, pp 93\u2013154"},{"key":"9737_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tvjl.2017.10.018","volume":"230","author":"JB King","year":"2017","unstructured":"King JB, Morton JM (2017) Incidence and risk factors for hypoadrenocorticism in dogs treated with trilostane. Vet J 230:24\u201329. \n                    https:\/\/doi.org\/10.1016\/j.tvjl.2017.10.018","journal-title":"Vet J"},{"key":"9737_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method. Methods 25:402\u2013408. \n                    https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"9737_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1677\/joe.0.0770111","volume":"77","author":"JC Meijer","year":"1978","unstructured":"Meijer JC, De Bruijne JJ, Rijnberk A, Croughs RJM (1978) Biochemical characterization of pituitary-dependent hyperadrenocorticism in the dog. J Endocrinol 77:111\u2013118. \n                    https:\/\/doi.org\/10.1677\/joe.0.0770111","journal-title":"J Endocrinol"},{"key":"9737_CR16","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.2307\/2880030","volume":"257","author":"KG Mountjoy","year":"1992","unstructured":"Mountjoy KG, Robbins LS, Mortrud MT, Cone RD, Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The Cloning of a Family of Genes That Encode the Melanocortin Receptors. Science 257:1248\u20131251. \n                    https:\/\/doi.org\/10.2307\/2880030","journal-title":"Science"},{"key":"9737_CR17","doi-asserted-by":"publisher","unstructured":"Nensey NK, Bodager J, Gehrand AL, Raff H (2016) Effect of novel melanocortin type 2 receptor antagonists on the corticosterone response to ACTH in the neonatal rat adrenal gland in vivo and in vitro. Front Endocrinol (Lausanne) 7. \n                    https:\/\/doi.org\/10.3389\/fendo.2016.00023","DOI":"10.3389\/fendo.2016.00023"},{"key":"9737_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jsap.12523","volume":"57","author":"DG O\u2019Neill","year":"2016","unstructured":"O\u2019Neill DG, Scudder C, Faire JM, Church DB, McGreevy PD, Thomson PC, Brodbelt DC (2016) Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary-care veterinary practices in the UK from 2009 to 2014. J Small Anim Pract 57:365\u2013373. \n                    https:\/\/doi.org\/10.1111\/jsap.12523","journal-title":"J Small Anim Pract"},{"key":"9737_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0039-128X(78)90010-7","volume":"32","author":"GO Potts","year":"1978","unstructured":"Potts GO, Creange JE, Harding HR, Schane HP (1978) Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 32:257\u2013267. \n                    https:\/\/doi.org\/10.1016\/0039-128X(78)90010-7","journal-title":"Steroids"},{"key":"9737_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cvsm.2009.10.008","volume":"40","author":"IK Ramsey","year":"2010","unstructured":"Ramsey IK (2010) Trilostane in Dogs. Vet Clin North Am Small Anim Pract 40:269\u2013283. \n                    https:\/\/doi.org\/10.1016\/j.cvsm.2009.10.008","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"9737_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jvim.12276","volume":"28","author":"LE Reid","year":"2014","unstructured":"Reid LE, Behrend EN, Martin LG, Kemppainen RJ, Ward CR, Lurye JC, Donovan TC, Lee HP (2014) Effect of trilostane and mitotane on aldosterone secretory reserve in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 28:443\u2013450. \n                    https:\/\/doi.org\/10.1111\/jvim.12276","journal-title":"J Vet Intern Med"},{"key":"9737_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/vr.160.7.219","volume":"160","author":"CE Reusch","year":"2007","unstructured":"Reusch CE, Sieber-Ruckstuhl N, Wenger M, Lutz H, Perren A, Pospischil A (2007) Histological evaluation of the adrenal glands of seven dogs with hyperadrenocorticism treated with trilostane. Vet Rec 160:219\u2013224. \n                    https:\/\/doi.org\/10.1136\/vr.160.7.219","journal-title":"Vet Rec"},{"key":"9737_CR23","doi-asserted-by":"publisher","unstructured":"Ruggiero C, Lalli E (2016) Impact of ACTH signaling on transcriptional regulation of steroidogenic genes. Front Endocrinol (Lausanne) 7. \n                    https:\/\/doi.org\/10.3389\/fendo.2016.00024","DOI":"10.3389\/fendo.2016.00024"},{"key":"9737_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jvim.13946","volume":"30","author":"K Sanders","year":"2016","unstructured":"Sanders K, Mol JA, Kooistra HS, Slob A, Galac S (2016) New Insights in the Functional Zonation of the Canine Adrenal Cortex. J Vet Intern Med 30:741\u2013750. \n                    https:\/\/doi.org\/10.1111\/jvim.13946","journal-title":"J Vet Intern Med"},{"key":"9737_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.domaniend.2017.11.001","volume":"63","author":"K Sanders","year":"2018","unstructured":"Sanders K, Mol JA, Slob A, Kooistra HS, Galac S (2018) Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study. Domest Anim Endocrinol 63:23\u201330. \n                    https:\/\/doi.org\/10.1016\/j.domaniend.2017.11.001","journal-title":"Domest Anim Endocrinol"},{"key":"9737_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0003-9861(73)90053-2","volume":"154","author":"S Seelig","year":"1973","unstructured":"Seelig S, Sayers G (1973) Isolated adrenal cortex cells: ACTH agonists, partial agonists, antagonists; cyclic AMP and corticosterone production. Arch Biochem Biophys 154:230\u2013239. \n                    https:\/\/doi.org\/10.1016\/0003-9861(73)90053-2","journal-title":"Arch Biochem Biophys"},{"key":"9737_CR27","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1186\/s13104-015-1628-4","volume":"8","author":"QEM Stassen","year":"2015","unstructured":"Stassen QEM, Riemers FM, Reijmerink H, Leegwater PAJ, Penning LC (2015) Reference genes for reverse transcription quantitative PCR in canine brain tissue. BMC Res Notes 8:761. \n                    https:\/\/doi.org\/10.1186\/s13104-015-1628-4","journal-title":"BMC Res Notes"},{"key":"9737_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1095\/biolreprod56.2.328","volume":"56","author":"DM Stocco","year":"1997","unstructured":"Stocco DM (1997) A StAR search: implications in controlling steroidgenesis. Biol Reprod 56:328\u2013336. \n                    https:\/\/doi.org\/10.1095\/biolreprod56.2.328","journal-title":"Biol Reprod"},{"key":"9737_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn I, Poppe B, Van Roy N, De Paepe A, Speleman R (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:34\u201331. \n                    https:\/\/doi.org\/10.1186\/gb-2002-3-7-research0034","journal-title":"Genome Biol"},{"key":"9737_CR30","first-page":"717","volume":"18","author":"P Willeberg","year":"1982","unstructured":"Willeberg P, Priester W (1982) Epidemiological aspects of clinical hyperadrenocorticism in dogs (Canine cushing\u2019s syndrome). J Am Anim Hosp Assoc 18:717\u2013723","journal-title":"J Am Anim Hosp Assoc"},{"key":"9737_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1210\/mend.11.3.9898","volume":"11","author":"YK Yang","year":"1997","unstructured":"Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, Barsh GS, Gantz I (1997) Effects of recombinant agouti-signaling protein on melanocortin action. Mol Endocrinol 11:274\u2013280. \n                    https:\/\/doi.org\/10.1210\/mend.11.3.9898","journal-title":"Mol Endocrinol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11259-018-9737-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-018-9737-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-018-9737-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:37:24Z","timestamp":1568939844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11259-018-9737-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["9737"],"URL":"https:\/\/doi.org\/10.1007\/s11259-018-9737-x","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"22 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}